An observational study in Multiple Sclerosis, sponsored by Boston Children's Hospital. Withdrawn at 1 site in United States. Open to participants aged 13 Years to 20 Years. Per ClinicalTrials.gov, last updated 2026-06-02.
Sponsored by Boston Children's Hospital · Observational
The goal of this research study is to to learn more about the body's immune response in patients with multiple sclerosis (MS). In MS, the body's immune cells mistakenly attack an important part of the nerves of the brain and spinal cord. The immune cells responsible for attacking the nerves in MS patients is primarily the T cells. A marker was recently discovered that might specifically identify these damaging T cells from all other T cells in the body. Understanding which T cells cause the damage in MS patients and understanding more about these specific T cells may help doctors better understand how MS occurs and could possibly prevent MS in the future.
3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.
Browse Multiple Sclerosis studies →Boston Children's Hospital is the lead sponsor of 598 studies on the registry; 151 are open to participants now.
Of its 31 completed or terminated interventional studies of FDA-regulated products, 18 (58%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients with Multiple Sclerosis who present to Boston Children's Hospital will be enrolled. A group of healthy control patients who present for elective surgery at Boston Children's Hospital will also be enrolled.
MS Group Inclusion criteria
-diagnosis of multiple sclerosis and present to the neurology clinic for a regular checkup or are admitted to the inpatient floor with acute symptoms.
Exclusion criteria
Control Group Inclusion criteria -scheduled for elective surgery
Multiple sclerosis patients presenting for a routine clinic visit.
Other: Blood Sample
Multiple sclerosis patients admitted to the hospital with acute symptoms.
Other: Blood Sample
Patients without any immunological diseases who present for elective surgery.
Other: Blood Sample
a blood sample will be collected
T cell populations
compare T cell populations between patients with Multiple Sclerosis and healthy controls
Time frame: up to one week
This study is withdrawn, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Boston Children's Hospital